30 Jan 2023 Publication Perspective NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents
6 Jan 2023 Animated Videos A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
5 Dec 2022 Animated Videos Nanoparticle surface-enhanced Raman spectroscopy as a tool to monitor hematological malignancy
21 Jun 2022 Animated Videos Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial
10 May 2022 Animated Videos A qualitative research study in Japan investigating patients’ experience with metastatic castration-resistant prostate cancer
12 Apr 2022 Oncology & Hematology TALAPRO-2: talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer
6 Apr 2022 Neurology & Psychiatry A pregnancy register cohort study among women with MS in Finland and Sweden
16 Aug 2021 Dermatology When should a PCP refer a patient with pustular psoriasis to a dermatologist?
6 Jan 2023 Animated Videos A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
21 Jun 2022 Animated Videos Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial
21 Apr 2020 Oncology & Hematology Adverse events in women switching from olaparib capsules to tablets: Retrospective observational study of US claims data
22 Nov 2021 Rare Diseases Plain language summary: Vosoritide treatment accelerates bone growth in children with achondroplasia
14 Feb 2020 Oncology & Hematology Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices
